子宫内膜癌前哨淋巴结阴性时淋巴血管间隙浸润预后价值消失
该回顾性研究纳入2007至2014年510例子宫内膜癌患者,排除淋巴结阳性者后分析413例,其中239例接受前哨淋巴结评估、174例仅行淋巴结清扫。前哨淋巴结阴性组中LVSI在多变量分析中与生存无显著关联,而淋巴结清扫阴性组LVSI仍为不良预后因素。
要点
- 前哨淋巴结阴性子宫内膜癌中LVSI不独立影响生存。
- 淋巴结清扫阴性者LVSI仍与较差OS和PFS相关。
- 提示前哨淋巴结评估可能改变LVSI的预后意义。
核心结论
- 在前哨淋巴结分期且淋巴结阴性的子宫内膜癌患者中,LVSI的预后价值消失,与淋巴结清扫阴性患者不同。
研究设计与样本
- 单中心回顾性研究,2007至2014年诊断子宫内膜癌510例,排除淋巴结阳性后纳入413例,239例行前哨淋巴结评估,174例行淋巴结清扫。
主要发现
- 前哨淋巴结组LVSI阳性者5年OS和PFS分别为80%和72%,LVSI阴性者为96%和93%。
- 淋巴结清扫组LVSI阳性者5年OS和PFS分别为74%和64%,LVSI阴性者为97%和90%。
- 多变量分析校正年龄、FIGO分期、分级和最大肿瘤大小后,前哨淋巴结组LVSI与OS和PFS均无显著关联。
- 淋巴结清扫组LVSI与OS和PFS仍显著相关。
关键数值与推荐
- 前哨淋巴结组OS:HR 1.2,CI [0.3-4.0],P = 0.8;PFS:HR 1.7,CI [0.7-4.3],P = 0.2。
- 淋巴结清扫组OS:HR 3.1,CI [1.4-6.5],P < 0.001;PFS:HR 2.5,CI [1.2-4.9],P = 0.01。
临床怎么用
- 对前哨淋巴结阴性子宫内膜癌患者,LVSI阳性可能不应单独作为强化辅助治疗的依据。
- 淋巴结清扫阴性且LVSI阳性者仍需关注复发风险。
局限性
- 为单中心回顾性研究。
- 结论需未来研究在前哨淋巴结阴性患者中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate if the prognostic value of lymphovascular space invasion (LVSI) is different in endometrial cancer patients with negative lymph nodes following sentinel lymph node (SLN) mapping or lymph node dissection (LND) as staging procedure. MATERIAL AND METHODS: A retrospective study of 510 patients diagnosed with endometrial carcinoma in our institution between 2007 and 2014. We excluded patients that were diagnosed with positive nodes (Stage IIIc). We compared patients' characteristics and survival outcomes as function of their LVSI status (positive LVSI vs negative LVSI subgroups) in each cohort separately. RESULTS: 413 patients met the inclusion criteria, out of whom 239 underwent SLN and 174 patients underwent LND only. In the SLN group, life table analysis showed 5-year OS and PFS of 80% and 72% in patients with LVSI compared to 96%, and 93% without LVSI. Same trend was observed among patients with LND with 5-year OS and PFS of 74% and 64% in patients with LVSI compared to 97%, and 90% without LVSI. On multivariable analysis, adjusted for age, FIGO stage, grade and maximal tumor size, the favorable survival of negative LVSI remained only in the LND cohort (SLN cohort: HR 1.2, CI [0.3-4.0], P = 0.8 and HR 1.7, CI [0.7-4.3], p = 0.2 for OS and PFS, respectively; LND cohort: HR 3.1, CI [1.4-6.5], p < 0.001 and HR 2.5, CI [1.2-4.9], p = 0.01 for OS and PFS, respectively). CONCLUSIONS: The prognostic value of LVSI disappears when patients undergo staging with SLN and are found to have negative nodes in contrast to those who have undergone LND. Future studies should confirm our observation on patients with negative sentinel nodes, and plan on tailoring adjuvant treatment to this specific subgroup.
引用
- Matanes E, Eisenberg N, Lau S, et al. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes. Gynecol Oncol. 2021. PMID: 34119364. doi:10.1016/j.ygyno.2021.05.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。